GFAP and Aicardi-Goutieres syndrome: What are more, investigations led by Campbell's group utilizing a transgenic mouse model expressing IFN-α in astrocytes specifically (GFAP-IFN), resulted in mice developing a clinical phenotype that overlapped with AGS individuals but lacked the genetic basis of AGS.